Brick & Kyle Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-15,377
| Closed | -$4.01M | – | 56 |
|
|
2024
Q4 | $4.01M | Buy |
15,377
+53
| +0.3% | +$15.7K | 1.71% | 25 |
|
|
2024
Q3 | $4.92M | Sell |
15,324
-192
| -1% | -$62.8K | 2.11% | 23 |
|
|
2024
Q2 | $4.85M | Buy |
15,516
+623
| +4% | +$183K | 2% | 20 |
|
|
2024
Q1 | $4.09M | Buy |
14,893
+2,759
| +23% | +$807K | 1.81% | 23 |
|
|
2023
Q4 | $3.5M | Sell |
12,134
-11
| -0.1% | -$3K | 1.74% | 24 |
|
|
2023
Q3 | $3.26M | Buy |
12,145
+10
| +0.1% | +$2.5K | 1.73% | 26 |
|
|
2023
Q2 | $2.74M | Buy |
12,135
+35
| +0.3% | +$8.12K | 1.47% | 29 |
|
|
2023
Q1 | $2.92M | Buy |
12,100
+312
| +3% | +$76.6K | 1.68% | 25 |
|
|
2022
Q4 | $3.1M | Sell |
11,788
-58
| -0.5% | -$15.5K | 1.8% | 23 |
|
|
2022
Q3 | $2.68M | Buy |
11,846
+118
| +1% | +$28.6K | 1.63% | 28 |
|
|
2022
Q2 | $2.85M | Sell |
11,728
-31
| -0.3% | -$7.6K | 1.6% | 28 |
|
|
2022
Q1 | $2.84M | Sell |
11,759
-11,621
| -50% | -$2.67M | 1.38% | 33 |
|
|
2021
Q4 | $5.26M | Buy |
23,380
+11,754
| +101% | +$2.48M | 1.22% | 34 |
|
|
2021
Q3 | $2.5M | Buy |
11,626
+621
| +6% | +$143K | 1.27% | 34 |
|
|
2021
Q2 | $2.67M | Sell |
11,005
-19
| -0.2% | -$4.67K | 1.4% | 32 |
|
|
2021
Q1 | $2.74M | Buy |
11,024
+7,870
| +250% | +$1.88M | 1.51% | 31 |
|
|
2020
Q4 | $722K | Buy |
3,154
+1,597
| +103% | +$368K | 0.45% | 46 |
|
|
2020
Q3 | $393K | Buy |
1,557
+5
| +0.3% | +$1.24K | 0.27% | 48 |
|
|
2020
Q2 | $362K | Buy |
1,552
+6
| +0.4% | +$1.37K | 0.27% | 52 |
|
|
2020
Q1 | $313K | Sell |
1,546
-103
| -6% | -$22.5K | 0.29% | 53 |
|
|
2019
Q4 | $397K | Buy |
1,649
+5
| +0.3% | +$1.1K | 0.3% | 49 |
|
|
2019
Q3 | $337K | Buy |
1,644
+101
| +7% | +$19.4K | 0.28% | 50 |
|
|
2019
Q2 | $279K | Buy |
1,543
+232
| +18% | +$41.5K | 0.26% | 56 |
|
|
2019
Q1 | $249K | Buy |
+1,311
| New | +$250K | 0.26% | 58 |
|
|
2017
Q4 | – | Sell |
-1,080
| Closed | -$201K | – | 100 |
|
|
2017
Q3 | $201K | Sell |
1,080
-145
| -12% | -$25.7K | 0.16% | 93 |
|
|
2017
Q2 | $211K | Buy |
1,225
+506
| +70% | +$82.3K | 0.18% | 91 |
|
|
2017
Q1 | $118K | Buy |
719
+1
| +0.1% | +$166 | 0.09% | 115 |
|
|
2016
Q4 | $105K | Hold |
718
| – | – | 0.08% | 122 |
|
|
2016
Q3 | $120K | Hold |
718
| – | – | 0.1% | 115 |
|
|
2016
Q2 | $109K | Hold |
718
| – | – | 0.09% | 124 |
|
|
2016
Q1 | $108K | Hold |
718
| – | – | 0.09% | 121 |
|
|
2015
Q4 | $117K | Hold |
718
| – | – | 0.1% | 112 |
|
|
2015
Q3 | $99K | Hold |
718
| – | – | 0.09% | 122 |
|
|
2015
Q2 | $110K | Buy |
718
+20
| +3% | +$3.2K | 0.09% | 128 |
|
|
2015
Q1 | $112K | Buy |
698
+357
| +105% | +$56.2K | 0.1% | 126 |
|
|
2014
Q4 | $54K | Buy |
+341
| New | +$53.1K | 0.05% | 171 |
|
Other funds holding AMGN
Brick & Kyle Associates's AMGN Position: Q1 2025 in Review
Brick & Kyle Associates sold out of Amgen (AMGN) in Q1 2025, closing a stake of 15,377 shares — an estimated $4.01M sold.
Brick & Kyle Associates first reported a position in AMGN in Q4 2014 and held it in 36 quarters. The position peaked at $5.26M in Q4 2021. 2,927 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.
- Brick & Kyle Associates reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
- Brick & Kyle Associates sold 15,377 Amgen shares in Q1 2025, an estimated $4.01M.
- Brick & Kyle Associates first reported a position in Amgen in Q4 2014 and held it in 36 quarters.
- Brick & Kyle Associates's Amgen position peaked at $5.26M in Q4 2021.
- 2,927 funds tracked by Wall St. Rank held Amgen as of Q1 2025.
Based on Brick & Kyle Associates's 13F filing for Q1 2025, filed 30 Apr 2025.